Novo’s main Ozempic plant cited for quality lapses by FDA
FortuneNovo has been racing to boost supplies of its drugs for obesity and diabetes after initially underestimating demand.
Novo has been racing to boost supplies of its drugs for obesity and diabetes after initially underestimating demand.